Continuum Advisory, LLC Zoetis Inc. Transaction History

Continuum Advisory, LLC

$778 Million
Q3 2024

A detailed history of Continuum Advisory, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 4,161 shares of ZTS stock, worth $685,899. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,161

Previous 4,112 1.19%

Holding current value

$685,899

Previous $712,000 14.04%

% of portfolio

0.1%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$172.58 - $196.48 $8,456 - $9,627	49 Added 1.19%	4,161 $812,000
Q2 2024 Jul 19, 2024	BUY	$145.54 - $178.83 $23,577 - $28,970	162 Added 4.1%	4,112 $712,000
Q1 2024 May 10, 2024	BUY	$165.67 - $199.94 $100,230 - $120,963	605 Added 18.09%	3,950 $668,000
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $25,896 - $34,215	171 Added 5.39%	3,345 $660,000
Q3 2023 Nov 13, 2023	SELL	$167.14 - $192.77 $7,688 - $8,867	-46 Reduced 1.43%	3,174 $552,000
Q2 2023 Dec 13, 2023	BUY	$160.94 - $186.23 $17,703 - $20,485	110 Added 3.54%	3,220 $554,000
Q2 2023 Aug 10, 2023	BUY	$160.94 - $186.23 $17,703 - $20,485	110 Added 3.54%	3,220 $554,000
Q1 2023 Dec 13, 2023	SELL	$145.48 - $175.02 $5,964 - $7,175	-41 Reduced 1.3%	3,110 $517,000
Q1 2023 May 12, 2023	SELL	$145.48 - $175.02 $5,964 - $7,175	-41 Reduced 1.3%	3,110 $517,000
Q4 2022 Dec 13, 2023	SELL	$131.14 - $157.47 $43,931 - $52,752	-335 Reduced 9.61%	3,151 $461,000
Q4 2022 Feb 10, 2023	SELL	$131.14 - $157.47 $43,931 - $52,752	-335 Reduced 9.61%	3,151 $461,000
Q3 2022 Dec 13, 2023	SELL	$148.29 - $182.55 $101,726 - $125,229	-686 Reduced 16.44%	3,486 $516,000
Q3 2022 Nov 08, 2022	SELL	$148.29 - $182.55 $101,726 - $125,229	-686 Reduced 16.44%	3,486 $517,000
Q2 2022 Dec 13, 2023	SELL	$155.97 - $200.09 $6,394 - $8,203	-41 Reduced 0.97%	4,172 $717,000
Q2 2022 Aug 15, 2022	SELL	$155.97 - $200.09 $6,394 - $8,203	-41 Reduced 0.97%	4,172 $717,000
Q1 2022 Dec 13, 2023	BUY	$181.39 - $234.03 $101,941 - $131,524	562 Added 15.39%	4,213 $794,000
Q1 2022 May 17, 2022	BUY	$181.39 - $234.03 $101,941 - $131,524	562 Added 15.39%	4,213 $747,000
Q4 2021 Dec 13, 2023	SELL	$193.69 - $247.03 $19,756 - $25,197	-102 Reduced 2.72%	3,651 $890,000
Q4 2021 Feb 14, 2022	SELL	$193.69 - $247.03 $19,756 - $25,197	-102 Reduced 2.72%	3,651 $891,000
Q3 2021 Dec 13, 2023	BUY	$189.29 - $209.69 $31,990 - $35,437	169 Added 4.72%	3,753 $728,000
Q3 2021 Nov 08, 2021	BUY	$189.29 - $209.69 $31,990 - $35,437	169 Added 4.72%	3,753 $729,000
Q2 2021 Dec 13, 2023	BUY	$155.9 - $187.99 $63,919 - $77,075	410 Added 12.92%	3,584 $667,000
Q2 2021 Aug 17, 2021	BUY	$155.9 - $187.99 $558,745 - $673,756	3,584 New	3,584 $668,000

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.

Account

Continuum Advisory, LLC Zoetis Inc. Transaction History